(Health-NewsWire.Net, April 11, 2017 ) According to the report Global Kidney Cancer Diagnostics and Therapeutics Market, published by Market Data Forecast, the global market is projected to reach USD 4.09 billion by 2021, at a CAGR of 5.64% from 2016 to 2021.
Kidney cancer is an illness in which the cells in specific tissues of the kidney begin to develop uncontrollably and form tumors. Renal cell carcinoma, which occurs in the cells covering the kidneys (epithelial cells), is the most widely recognized kind of kidney cancer. Eighty-five percent of all kidney tumors are renal cell carcinomas. Wilms' tumor is a quickly growing disease of the kidney frequently found in kids under four years old.
High-intensity focused ultrasound (HIFU) is a fairly a new method that is presently being examined for use in kidney cancer. It includes indicating extremely focused ultrasound beams from outside the body to destroy the tumor. Many new targeted therapies drugs are presently being tested. Also, with including cediranib and trebananib. Some of these are indicating promising results in early clinical trials.
Get sample report at http://www.marketdataforecast.com/market-reports/global-kidney-cancer-diagnostics-and-therapeutics-market-843/request-sample
The factors impacting the Global Kidney Cancer Diagnostics and Therapeutics Market, either positively or negatively are presented in the DROC analysis. Some of the things discussed in the section are rising aging population, Changes in lifestyle such as increased intake of alcohol and disproportionate smoking, and government policies to provide better care for kidney Cancer. However, high costs of screening tests, minimal success rate in clinical trials, and poor availability of proper cancer care in the emerging regions are restraining the growth of the market.
For granular level understanding the Kidney Cancer Diagnostics and Therapeutics Market is segmented based on the following categories with Market Size Estimations and Y-o-Y Forecasts presented for each sub-segment.
1. Based on Type:
Transitional Cell Cancer Renal cell carcinoma Renal sarcoma Others
2. Based on Tests:
Biopsy CT Scan Cystoscopy Intravenous pyelogram Kidney Ultrasound
Based on geography, the report contains a wide array of countries covering all around the globe. Countries like USA, Canada, U.K., Spain, Germany, Italy, India, China, South Africa, Israel and Brazil are identified as the predominant markets for Kidney Cancer Diagnostics and Therapeutics. For more of regional analysis check out the following reports.
North America Kidney Cancer Diagnostics and Therapeutics Market Europe Kidney Cancer Diagnostics and Therapeutics Market Asia-Pacific Kidney Cancer Diagnostics and Therapeutics Market Latin America Kidney Cancer Diagnostics and Therapeutics Market Middle East and Africa Kidney Cancer Diagnostics and Therapeutics Market
The major companies operating in the global Kidney Cancer Diagnostics and Therapeutics market are GlaxoSmithKline, Bayer, Pfizer, Sanofi S.A, Hoffmann La Roche, Novartis, Abbott Laboratories. The Pfizer companys drug, Sutent, improved the median disease-free survival rates for patients who had localized kidney cancer that was removed via surgery.
The Kidney Cancer Diagnostics and Therapeutics market study offers the following deliverables:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is blooming
Segment-level analysis on basis of type, tests along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail.
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that effect the global market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Diagnostics Segment:
Companion Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-companion-diagnostics-market-640/
In-vitro Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-in-vitro-diagnostics-market-146/
Preclinical In-vivo Imaging Market: http://www.marketdataforecast.com/market-reports/global-preclinical-in-vivo-imaging-market-582/
Nuclear Medicine Diagnostics Market: http://www.marketdataforecast.com/market-reports/global-nuclear-medicine-diagnostics-market-123/
Ultrasound Devices Market: http://www.marketdataforecast.com/market-reports/global-ultrasound-devices-market-575/
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com
|